The legal library gives you easy access to the FTC’s case information and other official legal, policy, and guidance documents.
In the Matter of The Coca-Cola Company; Analysis of Agreement Containing Consent Order to Aid Public Comment
20101186: Noble Group Limited; Sempra Energy
20101184: Noble Group Limited; The Royal Bank of Scotland Group plc
Novartis AG, In the Matter of (Alcon, Inc)
To settle FTC charges that its proposed acquisition of Alcon, Inc., would be anticompetitive, Novartis AG agreed to sell an injectable eye care drug used in cataract surgery. Novartis and Alcon are the only two U.S. providers of the class of drugs known as injectable miotics, and the FTC alleges that the acquisition would have created a monopoly in injectable miotics. The settlement requires Novartis to sell its drug Miochol-E to Bausch & Lomb, Inc.
FTC Comment Before the Federal Energy Regulatory Commission Concerning Demand Response Compensation in Organized Wholesale Energy Markets (Docket No. RM10-17-000)
Granting of Request for Early Termination of the Waiting Period Under the Premerger Notification Rules
20101176: Summit Partners Private Equity Fund VII-A, L.P.; Great Hill Equity Partners II, L.P.
16 C.F.R. Part 321: Mortgage Acts and Practices--Advertising Rule: Notice of Proposed Rulemaking; Request for Comment
Privacy Act of 1974; System of Records Notices; Correction
Innovative Systems Technology, Inc., et al.
PepsiCo, Inc., In the Matter of
The Commission required that carbonated soft drink company PepsiCo, Inc. restrict its access to confidential business competitive information of rival Dr Pepper Snapple Group as a condition for proceeding with PepsiCo’s proposed $7.8 billion acquisition of its two largest bottlers and distributors, which also distribute Dr Pepper Snapple Group carbonated soft drinks.